Deletion of the viral anti-apoptotic gene f1l in the hiv/ aids vaccine candidate mva-c enhances immune responses against hiv-1 antigens

HIGHLIGHTS

• who: AIDS Vaccine Candidate MVA-C and collaborators from the Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland, Division of Immunology and Allergy, Centre Hospitalier Universitaire have published the Article: Deletion of the Viral Anti-Apoptotic Gene F1L in the HIV/ AIDS Vaccine Candidate MVA-C Enhances Immune Responses against HIV-1 Antigens, in the Journal: PLOS ONE | www.plosone.org of October/31,/2012
• how: Because dendritic cells that have phagocytosed apoptotic infected cells cross-present viral to cytotoxic T cells inducing an antigen-specific immunity the authors hypothesized that deletion of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.